The LOXL1 mRNA is downregulated in RCC cell lines with VHL gene mutations, suggesting that the loss of LOXL1 expression is associated with RCC occurrence, but the specific molecular mechanisms involved remain unclear (Añazco et al., 2021). This evidence concerns the gene VHL and renal cell carcinoma.